Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 320 institutions that hold shares in the stock, with a total of 176 Million shares, which have been reported (via 13F filing form) to have a value of $6.41 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,255,361
shares
|
$44.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 57.33%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,251,617
shares
|
$43.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 9.02%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
1,224,282
shares
|
$43 Million
0.01% of portfolio
|
Q4 2024
Added 71.19%
|
|
Emerald Advisers, LLC
|
Feb 11, 2025 Q4 2024 |
1,150,868
shares
|
$40.4 Million
1.34% of portfolio
|
Q4 2024
Added 4.29%
|
|
Frontier Capital Management CO LLC
|
Feb 14, 2025 Q4 2024 |
1,075,858
shares
|
$37.8 Million
0.3% of portfolio
|
Q4 2024
Added 113.82%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
1,065,479
shares
|
$37.4 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
1,050,139
shares
|
$36.9 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
Feb 14, 2025 Q4 2024 |
1,023,950
shares
|
$36 Million
1.07% of portfolio
|
Q3 2024
Reduced 26.37%
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
1,015,728
shares
|
$35.7 Million
0.02% of portfolio
|
Q4 2024
Added 9.59%
|
|
Prosight Management, LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
995,000
shares
|
$34.9 Million
8.11% of portfolio
|
Q4 2024
Reduced 8.45%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
991,238
shares
|
$34.8 Million
0.0% of portfolio
|
Q4 2024
Added 22.3%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
940,415
shares
|
$33 Million
0.1% of portfolio
|
Q4 2024
New holding
|
|
Primecap Management CO
Pasadena, CA |
Feb 10, 2025 Q4 2024 |
915,500
shares
|
$32.1 Million
0.02% of portfolio
|
Q4 2024
Added 0.97%
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
905,279
shares
|
$31.8 Million
5.12% of portfolio
|
Q4 2024
Added 7.43%
|
|
Catalio Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
898,458
shares
|
$31.5 Million
5.39% of portfolio
|
Q4 2024
New holding
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
893,127
shares
|
$31.4 Million
0.0% of portfolio
|
Q4 2024
Added 4.16%
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
827,958
shares
|
$29.1 Million
0.03% of portfolio
|
Q4 2024
Reduced 0.63%
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
819,162
shares
|
$28.8 Million
0.99% of portfolio
|
Q4 2024
New holding
|
|
Emerald Mutual Fund Advisers Trust
|
Feb 14, 2025 Q4 2024 |
724,872
shares
|
$25.5 Million
1.37% of portfolio
|
Q4 2024
Reduced 3.52%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
678,857
shares
|
$23.8 Million
3.72% of portfolio
|
Q4 2024
Reduced 53.13%
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
664,924
shares
|
$23.3 Million
0.0% of portfolio
|
Q4 2024
Added 26.81%
|
|
683 Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
635,000
shares
|
$22.3 Million
1.25% of portfolio
|
Q4 2024
Added 15.45%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
609,588
shares
|
$21.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.68%
|
|
Cutter Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
560,344
shares
|
$19.7 Million
6.3% of portfolio
|
Q4 2024
Added 41.36%
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
532,192
shares
|
$18.7 Million
0.28% of portfolio
|
Q4 2024
Reduced 25.77%
|